Prior Art Litigation Search in San Diego.

Prior art search San Diego work splits down the middle, because the two industries that make this city a patent battleground could not be more different. On one side sits the world’s wireless capital, where Qualcomm and a dense 5G modem, RF and connectivity ecosystem generate standard-essential-patent and cellular disputes. On the other sits a top-tier life-sciences mesa, where Illumina, Thermo Fisher, Scripps Research, the Salk Institute and UC San Diego drive sequencing, antibody, diagnostic and small-molecule patents. A killer invalidity reference in a cellular case, a 3GPP contribution or an IETF draft, looks nothing like the killer reference in a biotech case, a journal article or a sequence-database deposit. Patents asserted against San Diego companies are litigated before the U.S. District Court for the Southern District of California, attacked in parallel through PTAB inter partes review, and sometimes fought at the International Trade Commission, with appeals to the Federal Circuit. PerspireIP runs two distinct prior-art playbooks and picks the right one for the claims in front of you.

Why prior art search San Diego cases run on two very different playbooks

Every prior art search San Diego matter starts with a triage question: is this a wireless case or a life-science case? The answer decides where the invalidating disclosure lives, how it has to be dated, and what a defensible obviousness argument even looks like. Getting that triage wrong wastes the search budget on the wrong corpus, and in fast-moving litigation there is rarely time for a second pass.

The split is not a marketing distinction. It reflects how the two dominant clusters in San Diego actually build technology. Cellular and connectivity companies develop their inventions inside standards bodies, publishing detailed technical contributions years before a patent issues, so the decisive art is standards documentation and open specifications. Life-science companies publish through peer-reviewed journals, conference abstracts, patent applications and public sequence and structure databases, so the decisive art is scientific literature with a provable publication date.

• Wireless / SEP playbook: 3GPP and ETSI contributions, change requests, IETF RFCs and drafts, IEEE 802 material, and vendor technical specifications as non-patent literature.
• Life-science playbook: journal articles, conference proceedings and abstracts, GenBank and PDB deposits, ClinicalTrials.gov records, and prior patent filings under Sections 102 and 103.

PerspireIP builds both records to the same evidentiary standard a Southern District judge or a PTAB panel expects, and maps every reference to the asserted claims element by element rather than handing counsel a raw list of hits.

San Diego’s wireless capital: Qualcomm, SEPs and the modem war

No U.S. city is more central to cellular patent litigation than San Diego. Qualcomm is headquartered here, and its CDMA, LTE and 5G portfolio has driven some of the largest standard-essential-patent and FRAND disputes in the world, including the multi-front war with Apple that produced a jury verdict in this very district and the earlier Broadcom standard-setting saga. Around Qualcomm sits a deep RF, modem, antenna, Wi-Fi and IoT ecosystem, so the patents asserted against San Diego companies are overwhelmingly about how a device implements a wireless standard.

That changes the invalidity problem. When a patent is declared essential to a 3GPP or IEEE standard, the state of the art is the standard’s own development record. Contributions, change requests, meeting minutes and working drafts circulated inside ETSI, 3GPP, IETF and IEEE working groups are public technical disclosures, frequently predating the asserted priority date, and they describe the claimed technique in far more detail than the granted patent does.

For a company accused of infringing a San Diego cellular patent, that public standards trail is the first place a defensible invalidity theory is found. The task is to locate the contribution that discloses the claimed feature and to prove exactly when it became available to the working group. A patent invalidation case built on the standard’s own record is far harder for a patentee to wave away than one built on loosely related patents.

The killer prior art in a San Diego wireless case

A prior art search San Diego wireless matter draws on a well-defined set of sources that a patent-only search never reaches. Each has its own way of establishing a public-availability date, which is the point most often attacked by the patentee.

• 3GPP TSG contributions (Tdocs), change requests and meeting reports across RAN, SA and CT working groups, dated to the meeting cycle.
• ETSI technical specifications and reports, plus the ETSI IPR database of declared essential patents for essentiality context.
• IETF RFCs and internet-drafts, and IEEE 802.11 and 802.16 draft standards and working-group ballots.
• Chipset and handset technical documentation, reference designs, application notes and developer guides.
• Academic and industry literature: IEEE conference proceedings, ICC and GLOBECOM papers, and vendor white papers.

The evidentiary hurdle is proving public availability at a precise date. Standards contributions are archived with meeting identifiers and upload timestamps, RFCs carry publication dates, and drafts are versioned, but a bare reference is not enough for a PTAB panel. We pin every document to a verifiable pre-priority date using working-group archives, versioning records and archive snapshots, so the reference survives a challenge to when the world could actually read it.

San Diego’s biotech mesa: Illumina, Scripps, Salk and UC San Diego

The second San Diego playbook is life sciences, anchored on the Torrey Pines mesa where UC San Diego, the Salk Institute, Scripps Research and Sanford Burnham Prebys sit within walking distance of one another and feed more than 400 biotech and pharma companies. Illumina made the region the global capital of DNA sequencing; Thermo Fisher, Neurocrine, Ligand and a wall of therapeutics and diagnostics companies fill out the cluster. The patents asserted here cover sequencing chemistry, antibodies, assays, formulations and small molecules.

These disputes are technically brutal and the stakes are enormous. Illumina’s globe-spanning next-generation-sequencing war with BGI and Complete Genomics ran through district courts, the PTAB and foreign courts at once, with sequencing-by-synthesis patents asserted, challenged and in several instances invalidated, and a nine-figure verdict changing hands. A single sequencing-chemistry or diagnostic-method patent can gate an entire product line.

For a life-science defendant the invalidity record looks completely different from a wireless one. The prior art is peer-reviewed science, and the questions turn on enablement, written description and whether a person of ordinary skill would have combined known techniques with a reasonable expectation of success. A defensible obviousness case here has to engage the biology, not just the citations.

The killer prior art in a San Diego life-science case

In a San Diego biotech or pharma matter the decisive references come from the scientific record rather than a standards body, and dating them precisely is again the real work of the search.

• Peer-reviewed journals: PubMed-indexed articles, plus supplementary data, with library accession and online-first publication dates.
• Conference abstracts and posters: AACR, ASHG, ASCO and Keystone proceedings that often disclose a method before any paper.
• Public sequence and structure databases: GenBank, the Protein Data Bank and UniProt deposits, dated by submission record.
• Clinical and regulatory records: ClinicalTrials.gov registrations, FDA labels and review documents showing a method in use.
• Earlier patents and published applications, and doctoral theses catalogued and shelved before the priority date.

Public availability is contested here too. A conference abstract has to be shown as distributed, a thesis as catalogued and accessible, an online article as posted on the date claimed. We build a public-availability timeline for every reference from indexing records, deposit histories, archived pages and library data, so counsel can defend each date if the patentee challenges it. That discipline is what separates a filing-ready invalidity record from a keyword report.

Where a San Diego patent fight is heard: S.D. Cal., PTAB, the ITC and the Federal Circuit

A patent asserted against a San Diego company is most often litigated in the U.S. District Court for the Southern District of California, which sits in downtown San Diego and has built real patent depth. During the national patent pilot program, roughly 80% of the district’s patent cases were concentrated on five judges, most of whom remain on the bench, and the district’s local patent rules impose a strict schedule of infringement and invalidity contentions, an early neutral evaluation conference and claim construction.

Those invalidity contentions are the pressure point. The local patent rules force a defendant to disclose its prior-art references and element-by-element invalidity charts early, so a defendant that starts searching after the case is filed is already behind the schedule. The prior art has to be substantially in hand before contentions are due.

• PTAB inter partes review (IPR). The most common parallel attack: a challenge at the USPTO on patents and printed publications, available after grant, deciding validity on a faster clock and a lower burden than district court.
• Post-grant review (PGR). A broader challenge, including under Sections 101 and 112, but only within nine months of issue for eligible patents.
• ITC Section 337. For imported devices, common in wireless and electronics cases, the Commission can order exclusion, so accused importers press invalidity fast before an Administrative Law Judge.
• Federal Circuit appeal. District court, PTAB and ITC decisions all appeal to one court in Washington, so the prior-art record has to hold up on review.

For an accused infringer, an IPR is often the sharpest tool, because the PTAB’s specialist panels read technical prior art closely and cancel claims on the same references that can be hard to land before a jury. The same underlying search supports the district court contentions, the IPR petition and any ITC defense, so the work is not redone as the forum shifts.

How PerspireIP builds a San Diego invalidity record

We start from the claims and the technology, not the keywords. A prior art search San Diego defendant relies on has to be organised the way Southern District invalidity contentions, an IPR petition or an ITC response need it, so each asserted claim is broken into elements and each element mapped to the art that reads on it, in either the wireless or the life-science corpus.

• Element-by-element claim charts with anticipation and obviousness mapping under Sections 102 and 103.
• Wireless track: deep retrieval across 3GPP, ETSI, IETF and IEEE archives, contributions, drafts and vendor documentation.
• Life-science track: journal, conference, sequence-database, clinical-trial and prior-patent retrieval with an eye to enablement and written description.
• Public-availability timelines pinning every reference to a verifiable pre-priority date.
• A written invalidity memo that grades the strength of each reference rather than just listing it.

We work under confidentiality as a search partner to your litigation counsel and patent attorneys, to the district’s contention deadlines and the PTAB’s statutory clocks. The work often runs alongside a broader prior art litigation search or a defensive patent infringement analysis, so validity and non-infringement positions come from one consistent evidence base.

We are candid about what we find. A search that surfaces only weak art is worth knowing early, while settlement, design-around and licensing options are still open and inexpensive, and our memos grade references honestly rather than overselling a case a San Diego company is about to bet a product line on.

IP Landscape & Resources in San Diego

Key intellectual-property authorities and venues relevant to San Diego:

• U.S. District Court for the Southern District of California — the federal trial court in San Diego that hears patent infringement and validity cases under its local patent rules
• USPTO Patent Trial and Appeal Board (PTAB) — decides inter partes review and post-grant review challenges to patent validity on prior art and printed publications
• U.S. International Trade Commission (ITC) — hears Section 337 investigations over imported products and can exclude infringing devices, a common venue in wireless and electronics disputes
• U.S. Court of Appeals for the Federal Circuit — the appellate court with exclusive jurisdiction over appeals from district courts, the PTAB and the ITC in patent cases

Request a Prior Art Search in San Diego

Explore related PerspireIP services: Prior Art Litigation Search · Patent Invalidation · Patent Infringement Analysis.

Frequently Asked Questions